Anti-DEspR antibody treatment improves survival and reduces neurologic deficits in a hypertensive, spontaneous intracerebral hemorrhage (hsICH) rat model von Herrera, Victoria L. M., Gromisch, Christopher M., Decano, Julius L., Pasion, Khristine Amber, Tan, Glaiza L. A., Hua, Ning, Takahashi, Courtney E., Greer, David M., Ruiz-Opazo, Nelson

Volltext

“Rogue” neutrophil-subset [DEspR+CD11b+/CD66b+] immunotype is an actionable therapeutic target for neutrophilic inflammation-mediated tissue injury – studies in human, macaque and... von Carstensen, Saskia, Müller, Meike, Tan, Glaiza L. A., Pasion, Khristine Amber, Hohlfeld, Jens M., Herrera, Victoria L. M., Ruiz-Opazo, Nelson

Volltext

Dual endothelin-1/VEGFsp receptor (DEspR): Common target on tumor vascular endothelial cells (TVECs), tumor cells (TCs), and cancer stem cells (CSCs) in glioblastoma and pancreatic... von Herrera, Victoria L.M., Tan, Glaiza L.A., Moran, Ann Marie, Pasion, Kristine A., Decano, Julius L, Ruiz-Opazo, Nelson

Volltext